ACE2 and COVID-19: As ACE2 expression was found to be upregulated in the brains of AD patients [19,20], it follows that SARS-CoV-2 infection has more available ACE2 receptors to bind and cause severe COVID-19 symptoms or exacerbate AD symptoms.